Search results for: 'harsh pain'

15 Oct 2024  |  Global  |  Technology Research

Emerging Non-opioid Treatments for Pain Management

Advances in Non-opioid Therapies for Neuropathic, Migraine, and Cancer Pain Management Unlock New Growth Opportunities

Infographics

×

The analysis explores cutting-edge advancements in non-opioid medications by delving into their mechanisms of action at a molecular scale, scrutinizing results from current clinical research initiatives, and appraising preparedness for and plausibility of regulatory approval. The considerations aim to highlight how these treatments may offer viable...

Over the past several decades drug therapies for clinically safe and effective management of various types of pain, classified as being acute, chronic, breakthrough, nerve, and bone-related have been treated with the use of opioids, NSAIDS, anticonvulsants and antidepressants. However, increasing reliance on their use for prolonged intervals and si...

Over the past several decades drug therapies such as analgesics, NSAIDs, and opioids have been used for the effective treatment of different types of acute, chronic, and injury-related pain. Dependence on these drug therapies have led to multiple side effects in human bodies and also addiction towards its consumption. Considering the direct and ind...

This research service provides an indepth analysis of factors affecting the growth of the U.S. opioid pain management market over the period 2006-2016. Included is a disease overview, product analysis, total market revenue forecasts, product revenue forecasts, patient forecasts, and market share analysis. The market is segmented by duration of acti...

The research provides technological advances and insights across non-opioid pharmaceuticals for the management of pain. Key application areas explored in the research include neuropathic pain, migrane, post-surgical pain, cancer pain, chronic pain and migraine. The research encompasses technological advances across Nav1.7 inhibitors, Calcitonin Gen...

This research benchmarks top participants in the global noise, vibration, and harshness (NVH) testing market. Of the more than 20 companies in this space, Frost & Sullivan identified 12 with commendable performance in the 7 key end-user segments (automotive, aerospace and defense [A&D], power generation, consumer electronics, construction, and indu...

This research service covers the U.S. opioid and non-opioid pain management pharmaceuticals markets and includes the long acting opioids, non-selective and selective non-steroidal anti-inflammatory drugs (NSAIDs). The research service provides a market overview, competitive structure, market forecasts and market share analysis across these two segm...

26 Jun 2020  |  Global  |  Market Research

Global Noise, Vibration and Harshness (NVH) Testing Market, Forecast to 2024

More Simulation-based Solutions Should Drive Market Revenues in the Coming Years

Infographics

×

This Frost & Sullivan research service analyzes the global noise, vibration and harshness (NVH) testing market in detail for the period covering 2018 to 2024, with 2019 as the base year. The study covers both the hardware and software segments. Hardware includes sensors, analyzers, sound level meters, microphones, data acquisition systems, signal c...

The construction industry is highly fragmented. It is focused on providing a wide range of professional services, including residential, non-residential, and engineering construction. While the industry typically tracks metrics related to construction activity, spend, growth, and competition, a significant challenge is to comprehend customer perspe...